Pulmonology & Respiratory Care

HAL / HAP Clinical Research

Hospital-Acquired Lung infections (HAL) and Hospital-Acquired Pneumonia (HAP) remain major challenges in acute care settings, requiring rapid diagnosis, advanced treatment strategies, and specialized clinical expertise. CenExel partners with sponsors to accelerate innovative respiratory and infectious disease research through experienced investigators, diverse patient populations, and high-performing research sites.

Studies Conducted
0 +
Trial Participants
0 +
Active Sites
0 +
Overview

Advancing HAL/HAP Clinical Research

CenExel provides comprehensive support for HAL and HAP clinical studies with specialized investigators, operational excellence, and access to diverse inpatient populations. Our experienced respiratory and infectious disease research teams help sponsors efficiently conduct trials from early feasibility through late-phase execution.

We focus on improving outcomes for patients affected by severe pulmonary infections while delivering high-quality data, regulatory compliance, and accelerated enrollment timelines.

 

Conditions Covered

HAL / HAP Conditions We Research

Our respiratory research teams support a wide range of pulmonary and hospital-acquired infection studies.

  • Hospital-Acquired Pneumonia (HAP)
  • Ventilator-Associated Pneumonia (VAP)
  • Acute Bacterial Pneumonia
  • Multi-Drug Resistant Pulmonary Infections
  • Severe Respiratory Infections
  • ICU-Associated Pulmonary Conditions
  • Complicated Lung Infections
  • Acute Respiratory Distress Conditions
Our Approach

Why Sponsors Choose CenExel for HAL / HAP

Our respiratory and infectious disease expertise supports efficient enrollment, strong data quality, and successful trial execution across acute-care settings.

01

Acute Care Expertise

Experienced investigators and site teams support complex inpatient respiratory infection studies.

02

Rapid Enrollment

Strong hospital partnerships enable faster identification and recruitment of eligible patients.

03

Advanced Site Infrastructure

Specialized equipment, trained coordinators, and streamlined workflows support efficient trial operations.

04

High-Quality Clinical Data

Robust monitoring and operational oversight ensure reliable study execution and regulatory compliance.

Phase Coverage

Supported HAL / HAP Trial Phases

CenExel supports respiratory and infectious disease studies from early-stage development through Phase IV trials.

Active across all phases
  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Our experienced respiratory research network helps sponsors execute studies efficiently across hospital and acute-care environments while maintaining high-quality patient care and data integrity.

HAL / HAP Task Force

CenExel supports respiratory and infectious disease research with specialized investigators, hospital-based recruitment strategies, and experienced clinical operations teams dedicated to improving outcomes in acute pulmonary care.

Active Sites

18 Sites

CenExel Phoenix
CenExel Anaheim
CenExel Atlanta
CenExel Marlton
CenExel Gaithersburg

Our Blog